Celldex Therapeutics, Inc.
SEC Filing List
CLDX CIK: 0000744218
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 8-K | Current report filing | Celldex Therapeutics, Inc. | Toppan Merrill/FA | 04/02/2026 | |
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | Celldex Therapeutics, Inc. | Toppan Merrill/FA | 04/02/2026 | |
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | Celldex Therapeutics, Inc. | Toppan Merrill/FA | 04/01/2026 | |
| SCHEDULE 13G/A | 03/26/2026 | ||||
| SCHEDULE 13G/A | SCHULTE ROTH & ZABEL LLP /fa | 03/10/2026 | |||
| 8-K | Current report filing | Celldex Therapeutics, Inc. | GLOBENEWSWIRE INC. /fa | 02/25/2026 | |
| 10-K | Annual report pursuant to Section 13 and... | Celldex Therapeutics, Inc. | Toppan Merrill/FA | 02/25/2026 | |
| SCHEDULE 13G/A | 02/10/2026 | ||||
| SCHEDULE 13G | 02/09/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Martin Samuel Bates | Celldex Therapeutics, Inc. | 01/06/2026 | |
| No record found. | |||||
| Load More | |||||
